Phenotyping pain in a mouse model of pancreatic cancer

胰腺癌小鼠模型的疼痛表型分析

• 批准号: 8290383
• 负责人: BRIAN M DAVIS
• 金额: $ 7.58万
• 依托单位: UNIVERSITY OF PITTSBURGH AT PITTSBURGH
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-07-01 至 2013-12-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8290383
• 关键词: Abdomen; Abdominal Pain; Adult; Affect; Aggressive behavior; Analgesics; Anatomy; Animal Cancer Model; Animal Model; Back Pain; Behavior; Behavioral; Biochemical; Biological Models; Breeding; Cancer Etiology; Carcinoma in Situ; Cessation of life; Clinical; Country; Data; Desmoplastic; Development; Diagnosis; Diagnostic Imaging; Disease; Disease Progression; Early Diagnosis; Euthanasia; Exhibits; Fiber; Foundations; Future; GDNF gene; Genetic; Goals; Growth; Growth Factor; Growth Factor Receptors; Human; Hypersensitivity; Hypertrophy; Incidence; Individual; Lesion; Longitudinal Studies; Malignant Neoplasms; Malignant neoplasm of pancreas; Measures; Modeling; Molecular; Mus; Mutation; Nerve; Nerve Growth Factors; Nervous system structure; Neurobiology; Nociceptors; Onset of illness; Operative Surgical Procedures; Pain; Pancreas; Pancreatic Ductal Adenocarcinoma; Patients; Peripheral; Peripheral Nervous System; Phenotype; Production; Protein p53; Quality of life; Research; Sensory; Sick Role; Skin; Stretching; Study models; Symptoms; Techniques; Testing; Time; Transgenic Mice; Transplantation; Tumor Cell Invasion; Tumor Cell Line; Tumor Suppressor Genes; United States; Visceral; Visceral Afferents; Western Blotting; Work; base; cancer pain; experience; gain of function; gait examination; human disease; intense pain; mortality; mouse model; nerve supply; neurophysiology; neurotrophic factor; novel; open field behavior; overexpression; pain behavior; pancreatic neoplasm; programs; receptor expression; research study; response; tumor; tumor growth

DESCRIPTION (provided by applicant): Pancreatic cancer, and specifically pancreatic ductal adenocarcinoma (PDAC), is among the five leading causes of cancer death in Western countries including the United States. Despite advances in diagnostic imaging and surgical techniques, mortality still approaches incidence as non-specific and often late symptoms complicate early detection and the frequent spread limit chances of cure. One of the important clinical manifestations of pancreatic cancer is pain. The often intense pain is thought to arise from invasion of tumor cells into the pancreatic nerves. This nerve-cancer interaction may also contribute to the aggressive behavior of pancreatic neoplasms. Together these findings suggest an intimate relationship between the peripheral nervous system and pancreatic cancer, wherein tumor-produced growth factors induce nerve sprouting and hypertrophy, increasing nerve-cancer interactions, which in turn promote cancer growth and invasion. We have begun to breed a transgenic mouse model that expresses the most common genetic lesions seen in human pancreatic cancer (a gain-of-function Kras mutations and loss of the p53 tumor suppressor gene) and develop tumors with virtually all of the features seen in the human disease. But before we develop a comprehensive program to exploit these mice for the study of cancer pain we need to determine if in fact they exhibit quantifiable pain behaviors, and whether these behaviors are correlated with changes in the peripheral sensory nervous system as has been seen in humans. Our hypothesis is that pancreatic cancer in Kras/p53 mice will produce pain behaviors that are correlated with tumor growth and the production of neurotrophic factors that have been shown to regulate anatomy and function of adult nociceptors (e.g., NGF and artemin). To test this hypothesis we will complete the following aims: SA1: Phenotype pain behaviors in Kras/p53 mice during progression of PDAC. a) Using Kras/p53 and control mice, we will conduct longitudinal studies of behaviors that should be affected by ongoing pain, including open field behavior, gait analysis, and hunching, as well as testing for the development of referred hypersensitivity (e.g., to abdominal skin). SA2: Test the hypothesis that PDAC increases neurotrophic factors (e.g. NGF, artemin, GDNF) and induces hypertrophy of visceral afferents . This hypothesis will be examined by: a) Determining changes in growth factor and growth factor receptor expression in pancreatic tumors (via real- time PCR, Western blots). b) Documenting changes in pancreatic innervation for growth factor dependent afferent fibers during the course of PDAC.

描述（由申请人提供）：胰腺癌，特别是胰腺导管腺癌（PDAC），是包括美国在内的西方国家癌症死亡的五个主要原因之一。尽管诊断成像和手术技术方面取得了进步，但死亡率仍将发病率视为非特异性且通常是晚期症状会使早期检测复杂化，并且频繁的治疗限制机会频繁。胰腺癌的重要临床表现之一是疼痛。人们认为，经常强烈的疼痛是由肿瘤细胞侵入胰腺神经引起的。这种神经癌的相互作用也可能有助于胰腺肿瘤的侵略行为。这些发现共同表明，周围神经系统与胰腺癌之间存在紧密的关系，其中肿瘤产生的生长因子诱导神经发芽和肥大，从而增加神经癌的相互作用，从而促进癌症的生长和侵袭。我们已经开始繁殖一种转基因小鼠模型，该模型表达了人类胰腺癌中最常见的遗传病变（功能功能获得的KRAS突变和p53肿瘤抑制基因的丧失），并发展出具有人类疾病中所有特征的肿瘤。但是，在我们制定一个综合程序来利用这些小鼠进行癌症疼痛的研究之前，我们需要确定实际上它们是否表现出可量化的疼痛行为，以及这些行为是否与外围感觉神经系统的变化相关，如人类所见。我们的假设是，KRAS/p53小鼠中的胰腺癌将产生与肿瘤生长相关的疼痛行为，以及已证明可以调节成年伤害感受器（例如NGF和Artemin）的解剖学和功能的神经营养因子的产生。为了检验该假设，我们将完成以下目的：SA1：PDAC进展过程中KRAS/p53小鼠的表型疼痛行为。 a）使用KRAS/p53和对照小鼠，我们将对应受到持续疼痛影响的行为进行纵向研究，包括开放式行为，步态分析和驼背，并测试引用过敏性过敏性（例如，到腹部皮肤）的发展。 SA2：检验PDAC增加神经营养因子（例如NGF，Artemin，GDNF）和诱导内脏传入肥大的假设。该假设将通过：a）确定胰腺肿瘤中生长因子和生长因子受体表达的变化（通过实时PCR，Western印迹）。 b）记录PDAC过程中依赖生长因子的传入纤维的胰神经支配的变化。